Orphan Drug Designation

SICKLE CELL DISEASE | FDA Grants Orphan Drug Designation to AND017

Announced by KIND Pharmaceuticals on October 25, 2024, ODD is granted to a drug or biological product to prevent, diagnose, or treat a rare disease or condition that affects fewer…

Read More »